Subfoveal Neovascular Age-related Macular Degeneration

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2017-01-02
Clinical Trial Update: A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial) [Phase 1, Phase 2]
This terminated Phase 1/2 trial (Super-dose Anti-VEGF SAVE Trial) evaluated intravitreal 2.0 mg ranibizumab for chronic OCT fluid after prio…